Gestational Surrogacy in India: A Complete Guide

Gestational surrogacy is a third-party reproduction arrangement in which a woman carries a pregnancy created through in vitro fertilization (IVF). The embryo is formed from the egg and sperm of the intended parents or donors -- not from the surrogate's own egg. This means the gestational carrier has no genetic relationship to the child she carries.

The surrogate's role is biological but not genetic. Her uterus provides the environment for the embryo to implant, grow, and develop. After delivery, the child is handed over to the intended parents, who are the legal parents from birth under Indian law.

Gestational Surrogacy vs. Traditional Surrogacy

The distinction between these two forms of surrogacy is fundamental and has significant legal, medical, and emotional implications:

Gestational surrogacy (also called host surrogacy or full surrogacy):

• The embryo is created via IVF using the intended parents' eggs and sperm, or donor gametes
• The surrogate contributes no genetic material
• The child's DNA comes from the egg provider and the sperm provider only
• This is the only form of surrogacy permitted in India under the Surrogacy Act 2021

Traditional surrogacy (also called partial surrogacy or genetic surrogacy):

• The surrogate's own egg is used, typically fertilized via intrauterine insemination (IUI) with the intended father's sperm
• The surrogate is both the gestational and genetic mother
• This creates a genetic link between the surrogate and the child
• Traditional surrogacy is not permitted in India under the current law

Why Gestational Surrogacy Is Preferred Medically

Beyond the legal mandate in India, gestational surrogacy is the global standard in reproductive medicine for several reasons:

• Genetic clarity: The child is genetically related to the intended parents (or their chosen donors), not the surrogate, which simplifies legal parentage
• Medical control: IVF allows comprehensive embryo selection, including preimplantation genetic testing (PGT) where indicated
• Emotional boundaries: The absence of a genetic link between surrogate and child helps establish clearer psychological boundaries for all parties
• Higher success rates: IVF with controlled embryo transfer achieves higher pregnancy rates than IUI-based traditional surrogacy

Surrogacy is not a first-line fertility treatment. It is considered only when a woman cannot carry a pregnancy to term, either because she has no uterus, her uterus cannot sustain a pregnancy, or pregnancy poses serious medical risks. The primary medical indications include:

Absent Uterus (Congenital or Surgical)

Women born without a uterus -- a condition called Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome -- cannot carry a pregnancy. MRKH affects approximately 1 in 4,500 women. Similarly, women who have undergone a hysterectomy (surgical removal of the uterus) due to cancer, severe fibroids, uncontrollable postpartum haemorrhage, or other conditions have no uterus to sustain a pregnancy. For these women, surrogacy is the only option to have a genetically related child.

Non-Functional or Severely Damaged Uterus

Some women have a uterus that is anatomically present but cannot support a pregnancy. This includes:

• Severe Asherman syndrome: Extensive intrauterine adhesions (scar tissue) that destroy the endometrial lining and cannot be surgically corrected
• Severe uterine anomalies: Unicornuate uterus with recurrent pregnancy loss, or other mullerian anomalies not amenable to surgical repair
• Radiation damage: Prior pelvic radiation therapy that has permanently damaged the uterine lining and blood supply
• Severe adenomyosis: Extensive adenomyosis that causes repeated implantation failure despite treatment

Repeated IVF and Implantation Failure

When a couple has undergone multiple IVF cycles with good-quality embryos (including PGT-tested euploid embryos) but the embryos consistently fail to implant despite optimal endometrial preparation, the uterine environment may be the limiting factor. After exhaustive evaluation -- including hysteroscopy, endometrial receptivity testing, and immunological assessment -- surrogacy may be recommended as the next step.

Medical Contraindications to Pregnancy

Some women have medical conditions that make pregnancy life-threatening:

• Severe cardiac disease: Pulmonary hypertension, Eisenmenger syndrome, severe aortic stenosis, or a history of peripartum cardiomyopathy
• Uncontrolled autoimmune disorders: Severe systemic lupus erythematosus (SLE) with renal involvement or antiphospholipid syndrome refractory to treatment
• History of life-threatening pregnancy complications: Severe preeclampsia, HELLP syndrome, or placenta accreta in previous pregnancies
• Active cancer or recent cancer treatment: Where pregnancy hormones could stimulate tumour recurrence

Recurrent Pregnancy Loss

When a woman has experienced multiple miscarriages or stillbirths despite thorough investigation and treatment -- including correction of uterine anomalies, management of thrombophilia, and immunomodulatory therapy -- and the losses are attributed to uterine factors, surrogacy may be considered.

India was once the world's largest commercial surrogacy hub, with an estimated industry worth over $400 million annually and thousands of foreign intended parents seeking affordable surrogate mothers. In response to concerns about exploitation of economically vulnerable women, lack of oversight, and commodification of reproduction, the Indian government enacted the Surrogacy (Regulation) Act 2021, which fundamentally transformed the surrogacy landscape.

The Act came into effect on January 25, 2022, alongside the Assisted Reproductive Technology (Regulation) Act 2021. Together, these two laws create a comprehensive regulatory framework for all third-party reproduction in India.

Core Principles of the Act

1. Altruistic surrogacy only: No payment, reward, or financial incentive may be given to the surrogate beyond medical expenses and insurance. Commercial surrogacy is a criminal offence.
2. Indian married couples only: Surrogacy is restricted to legally married Indian heterosexual couples with documented medical need.
3. Close relative as surrogate: The surrogate must be a "close relative" of the intended couple (this was subsequently amended -- see below).
4. Single embryo transfer: Only one embryo may be transferred per cycle to prevent multiple pregnancies.
5. No sex selection: Determination of the sex of the surrogate child is prohibited.

Who Can Commission Surrogacy (Intended Parents)

The Surrogacy Act 2021 and its rules set strict eligibility criteria for intended parents:

• Marital status: Must be a legally married Indian couple. The marriage must have been subsisting for at least 5 years at the time of application (this requirement was introduced in the 2023 amendment).
• Nationality: Both partners must be Indian citizens. Foreign nationals, Overseas Citizens of India (OCI), and Persons of Indian Origin (PIO) are not eligible.
• Age: The female partner must be between 23 and 50 years. The male partner must be between 26 and 55 years.
• Medical necessity: The couple must produce a certificate of essential need for surrogacy, issued by a district medical board. This certificate must document that the woman cannot carry a pregnancy due to one of the recognized medical indications.
• No living children: The couple must not have a surviving child (biological, adopted, or through surrogacy). An exception is made if the existing child has a mental or physical disability or suffers from a life-threatening disorder. Children from a previous marriage who are not in the custody of the intended parents are also excepted.
• No previous surrogacy: The couple must not have previously commissioned surrogacy.

Who Can Be a Surrogate

The Act sets the following requirements for gestational surrogates:

• Marital status: Must be a married woman with at least one living child of her own
• Age: Between 25 and 35 years
• Number of surrogacies: Can act as a surrogate only once in her lifetime
• Medical fitness: Must be certified medically and psychologically fit by the registered medical practitioner
• Relationship to intended parents: The 2021 Act originally required the surrogate to be a "close relative" of the intending couple. The 2023 amendment broadened this to allow any willing woman who meets the eligibility criteria, removing the close relative requirement. However, states may interpret this differently in practice.
• Consent: Must provide written, informed consent. The surrogate must not be coerced, induced, or unduly influenced
• No gamete contribution: The surrogate must not contribute her own egg (gestational surrogacy only)

The "Close Relative" Controversy and 2023 Amendment

The original Act's requirement that the surrogate be a "close relative" of the intended couple proved deeply problematic. The term "close relative" was not defined in the Act, creating confusion. More practically, many couples could not find a willing female relative who met all the eligibility criteria (married, 25-35, with a child, willing to undergo the physical demands of surrogacy).

In March 2023, the government amended the Surrogacy (Regulation) Rules to remove the mandatory "close relative" requirement. The amendment allows any willing woman who meets the eligibility criteria to serve as a gestational surrogate, provided she does so altruistically (without payment beyond medical expenses and insurance). This amendment significantly expanded access to surrogacy for eligible Indian couples.

Consent and Legal Parentage

The Act establishes clear rules about consent and parentage:

• Written consent: Both the intended parents and the surrogate (and the surrogate's spouse) must provide written, informed consent before a surrogacy agreement can be executed
• Surrogacy agreement: A legally binding agreement must be executed between the intended parents and the surrogate before the surrogacy procedure begins. This agreement specifies the rights, obligations, and responsibilities of both parties
• Legal parentage: The child born through surrogacy is deemed the biological child of the intending couple from the moment of birth. The surrogate relinquishes all parental rights
• Birth certificate: The intended parents' names appear on the birth certificate. The surrogate's name does not appear
• Abortion rights: If the surrogate wishes to terminate the pregnancy, she can do so under the Medical Termination of Pregnancy Act, but with the written consent of the intended parents (except in cases where continuation of pregnancy is life-threatening to the surrogate)

Insurance Requirement

The intended couple must take out a comprehensive insurance policy covering the surrogate for a period of 36 months from the date of embryo transfer. This insurance must cover:

• All pregnancy-related medical expenses
• Complications arising during pregnancy, delivery, and postpartum period
• Any health consequences of the surrogacy process
• Post-delivery health monitoring

Regulatory Bodies

The Act creates a multi-tier regulatory structure:

• National Surrogacy Board: Chaired by the Union Health Minister, responsible for policy, guidelines, and oversight
• State Surrogacy Boards: Established in each state to monitor implementation
• Appropriate Authority: District-level authorities that process surrogacy applications, inspect clinics, and enforce compliance
• Registration: All surrogacy clinics must be registered with the appropriate authority. Operating without registration is a criminal offence

Penalties for Violations

The Surrogacy Act imposes severe penalties:

The surrogacy process in India involves legal, medical, and emotional dimensions that unfold over approximately 12 to 18 months from initial consultation to delivery. Here is how each phase works:

Step 1: Medical Evaluation and Surrogacy Recommendation

The process begins with a thorough medical evaluation of the intended mother to establish that she cannot carry a pregnancy. This evaluation includes:

• Detailed gynaecological history and examination
• Uterine assessment (hysteroscopy, ultrasound, MRI if needed)
• Review of previous pregnancy and IVF outcomes
• Assessment of the medical condition contraindicating pregnancy
• Fertility assessment of both partners (ovarian reserve, semen analysis)

If the fertility specialist determines that surrogacy is medically indicated, they issue a certificate of essential need. This certificate forms the basis of the legal application.

Step 2: Legal Clearance and Surrogacy Agreement

Before any medical procedure can begin, the intended parents must obtain legal clearance:

• Application to the Appropriate Authority: The couple submits an application to the district-level Surrogacy Appropriate Authority, along with the medical certificate, marriage certificate, identity documents, and the surrogacy agreement
• Surrogacy agreement: A legal agreement between the intended parents and the surrogate, drafted with legal counsel, specifying responsibilities, financial arrangements (medical expenses and insurance), consent for procedures, parentage, and contingencies (including multiple pregnancy, disability, divorce of intended parents, or death of any party)
• Surrogate identification: The intended parents identify a willing surrogate who meets all eligibility criteria. If the surrogate is not a close relative, she must meet the amended rule requirements
• Insurance: The intended couple procures a 36-month insurance policy for the surrogate before the agreement is signed
• Approval timeline: The Appropriate Authority reviews the application and may approve, request additional information, or reject. Typical processing takes 2-4 weeks, though delays are common depending on the state

Step 3: Medical Screening of the Surrogate

Once legal clearance is obtained, the identified surrogate undergoes comprehensive screening:

• General medical examination: Complete physical examination, BMI assessment, blood pressure, thyroid function
• Gynaecological evaluation: Pelvic ultrasound, uterine cavity assessment, cervical screening
• Infectious disease screening: HIV, Hepatitis B and C, syphilis, and other STIs
• Blood group and Rh typing: To assess compatibility and plan for Rh sensitization prevention
• Haematological screening: Complete blood count, haemoglobin electrophoresis (thalassemia screening)
• Psychological assessment: Evaluation of the surrogate's understanding of the process, motivations, emotional readiness, and coping mechanisms
• Substance use assessment: Screening for alcohol, tobacco, and drug use
• Prior obstetric history review: Detailed review of previous pregnancies, deliveries, and complications

Step 4: IVF and Embryo Creation

With legal approval and surrogate screening complete, the IVF process begins:

• Ovarian stimulation of the intended mother (or egg donor): The intended mother undergoes standard IVF ovarian stimulation with gonadotropins for 10-12 days, followed by egg retrieval. If the intended mother's eggs are not available (absent ovaries, POI), a donor egg cycle through an ICMR-registered ART bank is arranged
• Sperm collection: The intended father provides a semen sample (or donor sperm is arranged if indicated)
• Fertilization: Eggs are fertilized via ICSI in the laboratory
• Embryo culture: Embryos are cultured to the blastocyst stage (Day 5-6)
• PGT (if indicated): Preimplantation genetic testing may be performed if recommended based on the intended parents' history
• Embryo vitrification: All embryos are frozen while the surrogate's endometrium is prepared

Step 5: Endometrial Preparation and Embryo Transfer to the Surrogate

The surrogate's uterine lining is prepared to receive the embryo:

• Cycle synchronization or HRT protocol: The surrogate takes estrogen (oral, transdermal, or intramuscular) beginning on cycle day 2-3 for approximately 12-14 days to develop the endometrial lining
• Progesterone supplementation: Once the lining reaches 8 mm or more, progesterone is added to convert the endometrium to the receptive (secretory) phase
• Embryo transfer: A single vitrified blastocyst is thawed and transferred to the surrogate's uterus under ultrasound guidance. The Surrogacy Act mandates single embryo transfer to minimize the risks associated with multiple pregnancy
• Pregnancy test: Serum beta-hCG is measured 10-14 days after transfer

Step 6: Pregnancy Monitoring

If the pregnancy test is positive, the surrogate enters regular prenatal care:

• Early ultrasound at 6-7 weeks to confirm clinical pregnancy and heartbeat
• First trimester screening: NT scan, blood tests, and NIPT (non-invasive prenatal testing) if recommended
• Regular antenatal visits: Monthly visits through the second trimester, biweekly in the third trimester, and weekly near term
• Monitoring for complications: Gestational diabetes screening, blood pressure monitoring, fetal growth ultrasounds
• Emotional support: Ongoing psychological support for the surrogate and the intended parents throughout the pregnancy
• Communication protocol: Agreed-upon communication schedule between the surrogate and intended parents, as outlined in the surrogacy agreement

Step 7: Delivery and Parentage

The final phase is the delivery and legal handover:

• Delivery planning: The intended parents and surrogate jointly decide on the delivery hospital and birth plan, consistent with the surrogacy agreement
• Delivery: The surrogate delivers the baby (vaginal delivery or caesarean section as medically indicated)
• Immediate handover: The child is handed to the intended parents at birth or as soon as medically appropriate
• Birth certificate: The intended parents' names are recorded on the birth certificate. The surrogate's name does not appear
• Post-delivery care for the surrogate: The surrogate receives postpartum medical care covered by the insurance policy, including follow-up for any pregnancy-related complications

Gestational surrogacy success rates are essentially the success rates of the underlying IVF cycle combined with the surrogate's proven fertility and uterine receptivity. Because surrogates are selected specifically for their reproductive health and history of successful pregnancies, surrogacy often achieves higher pregnancy rates per transfer than standard IVF.

Per-Transfer Clinical Pregnancy Rates

• With intended mother's eggs (age <35): 50-60% clinical pregnancy rate per frozen embryo transfer
• With intended mother's eggs (age 35-39): 40-50% clinical pregnancy rate per transfer
• With intended mother's eggs (age 40+): 25-35% clinical pregnancy rate per transfer
• With donor eggs: 55-65% clinical pregnancy rate per transfer (age-independent)
• With PGT-tested euploid embryos: 60-70% clinical pregnancy rate per transfer

Live Birth Rates

Live birth rates are approximately 8-12 percentage points lower than clinical pregnancy rates, accounting for miscarriage. With PGT-tested euploid embryos transferred to a screened surrogate, live birth rates of 55-65% per transfer are achievable.

Cumulative Success

Because surrogacy involves frozen embryo transfers and the intended parents typically have multiple embryos available, the cumulative live birth rate over 2-3 transfer cycles is 70-85% or higher, depending on embryo quality and number.

Factors Affecting Surrogacy Success

• Egg quality (determined by egg provider's age): The single most important factor
• Embryo quality: Blastocyst grade and chromosomal status
• Surrogate selection: Proven fertility, healthy uterus, absence of complications in prior pregnancies
• Endometrial preparation: Adequate lining thickness and receptivity at the time of transfer
• Sperm quality: Severe male factor may affect embryo quality despite ICSI
• Laboratory quality: Embryo culture conditions, vitrification/thaw survival rates

Gestational surrogacy is among the most emotionally complex forms of family building. All parties -- the intended parents, the surrogate, and her family -- navigate profound psychological territory.

For Intended Parents

The decision to pursue surrogacy typically follows a long and painful journey through infertility, failed treatments, and the grief of not being able to carry a pregnancy. Common emotional experiences include:

• Grief and loss: Mourning the inability to experience pregnancy and childbirth
• Guilt: Feeling guilty about "using" another woman's body, even in altruistic arrangements
• Anxiety: Fear of complications, surrogate's health, legal uncertainties, and attachment concerns
• Loss of control: The experience of pregnancy happening in someone else's body can feel disorienting
• Gratitude and complexity: Deep gratitude toward the surrogate, mixed with uncertainty about the relationship dynamics

For the Surrogate

Surrogates in altruistic arrangements face their own emotional landscape:

• Altruistic motivation: Genuine desire to help a couple or family member achieve parenthood
• Physical demands: Pregnancy carries inherent risks, including morning sickness, fatigue, gestational diabetes, preeclampsia, and the physical recovery from delivery
• Emotional attachment: Even without a genetic link, carrying a pregnancy for 9 months creates a biological bond. The process of relinquishing the baby requires emotional preparation
• Family dynamics: The surrogate's own family -- her spouse, her children -- are affected by the surrogacy. Her children need age-appropriate explanations
• Social stigma: In parts of Indian society, surrogacy (even altruistic) may carry social stigma. Surrogates may face judgment or misunderstanding from their community

Ethical Dimensions

The ethical debate around surrogacy in India has been shaped by the country's experience with unregulated commercial surrogacy before 2021:

• Exploitation concerns: The pre-2021 commercial surrogacy industry raised serious concerns about exploitation of economically disadvantaged women who served as surrogates primarily for financial survival
• Autonomy and consent: Genuine informed consent requires that the surrogate understands the medical risks, emotional implications, and legal consequences without any form of coercion
• Altruistic vs. commercial: India's shift to altruistic-only surrogacy aims to remove the financial incentive that could undermine voluntary consent. Critics argue this approach limits access and may drive surrogacy underground
• Equity of access: The current law restricts surrogacy to married Indian couples, excluding single individuals, same-sex couples, and foreign nationals. This raises questions about equitable access to reproductive options

Counselling Recommendations

The Surrogacy Act mandates psychological assessment of the surrogate. Best practice extends this to comprehensive counselling for all parties:

• Pre-surrogacy counselling: For both the intended parents and the surrogate, addressing expectations, boundaries, communication, contingency planning
• During pregnancy: Ongoing psychological support, particularly for the surrogate as the pregnancy progresses
• Post-delivery: Counselling for the surrogate to process the relinquishment, and for the intended parents as they transition into parenthood through surrogacy

Since commercial surrogacy is prohibited, the costs of surrogacy in India are limited to medical expenses, legal fees, and mandatory insurance for the surrogate. There is no "surrogacy fee" paid to the surrogate -- only reimbursement for medical expenses and related costs incurred during the process.

Cost Breakdown

Cost by City Tier

• Tier 2 cities (Jaipur, Lucknow, Indore, Nagpur): ₹5,00,000 - 8,00,000
• Metro cities (Mumbai, Delhi-NCR, Bangalore, Hyderabad, Chennai): ₹7,00,000 - 12,00,000
• Premium IVF centres with surrogacy programmes: ₹10,00,000 - 15,00,000+

Important Cost Considerations

• Multiple transfer cycles: If the first embryo transfer does not result in pregnancy, subsequent FET cycles add ₹40,000-80,000 each plus surrogate medications
• Donor egg surrogacy: If the intended mother cannot provide eggs, adding a donor egg cycle increases costs by ₹1,50,000-3,00,000
• PGT testing: If preimplantation genetic testing is recommended, add ₹60,000-1,20,000
• Complications: Pregnancy complications requiring hospitalization, bed rest, or specialized care increase costs. The surrogate's insurance is intended to cover these, but gaps may exist
• No surrogacy fee: Unlike commercial surrogacy (which previously cost ₹10-20 lakh for the surrogate fee alone), altruistic surrogacy eliminates this cost. However, all legitimate medical, nutritional, and incidental expenses of the surrogate must be covered

Selecting the right fertility centre for your surrogacy journey is a critical decision. Consider the following:

1. Registration: Verify that the clinic is registered with the appropriate authority under both the Surrogacy Act and the ART Act. Operating without registration is illegal.

1. Surrogacy experience: Ask about the number of surrogacy cases the centre has managed, their pregnancy and live birth rates with surrogacy, and their experience with the legal process.

1. Legal support: A reputable centre should have legal counsel or legal partners experienced in surrogacy law who can assist with the surrogacy agreement, Appropriate Authority applications, and birth certificate procedures.

1. Surrogate screening and support: Ask about the centre's surrogate screening protocols, psychological support services, and ongoing monitoring during pregnancy.

1. Transparency: The centre should provide a detailed, written cost breakdown and timeline at the outset, with no hidden fees or vague estimates.

1. Counselling services: Access to a reproductive psychologist or counsellor experienced in surrogacy for both the intended parents and the surrogate.

1. Post-delivery support: The centre should have a protocol for surrogate post-delivery care and follow-up, as mandated by the insurance requirement.